Market Tracker

10/31 4:43pm ET

Nektar Therapeutics (NASDAQ:NKTR)

During the Trading Day
13.79 -0.24 / -1.71%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.79 +0.0072 / +0.05%
 
Volume: --
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close14.03
Today’s open14.34
Day’s range13.65 - 14.44
Volume886,142
Average volume (3 months)1,280,566
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+53.84%
Earnings growth (next 5 years)+35.25%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABCOAdvisory Board Co+0.71+1.34%
DYAXDyax Corp+0.08+0.61%
KERXKeryx Biopharmaceuti...+0.28+1.69%
ARIAARIAD Pharmaceutical...-0.01-0.17%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.39
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts